IL-GLOBAL-DAIRY
26.7.2021 11:02:07 CEST | Business Wire | Press release
A first-of-its-kind Pathways to Dairy Net Zero initiative is being developed to accelerate climate change action throughout the global dairy sector. Announced today at the United Nations (UN) Food Systems Pre-Summit, the climate effort will be unlike any other in agriculture in terms of size, breadth, and scope.
“The global dairy sector is creating this ground-breaking initiative to help speed climate action already underway, while continuing to provide livelihoods for a billion people and important nutrition for six billion people,” said Donald Moore, Executive Director at the Global Dairy Platform.
A multi-stakeholder group of organizations, including the global dairy sector and representatives from the scientific and research communities, are working together to develop methodologies, tools and pathways that work for every dairy system. Pathways to Dairy Net Zero will officially launch during the UN Food Systems Summit in September and aims to generate commitments at the UN Climate Change Conference, COP26, in November.
New research to guide the initiative
Research is underway to identify where positive climate change action is possible across all dairy production systems and regions throughout the world. The study is being conducted by the Global Research Alliance on Agricultural Greenhouse Gases (GRA), the UN Food and Agriculture Organisation, Scotland’s Rural College and the New Zealand Agricultural Greenhouse Gas Research Centre. Preliminary findings include:
- Positive change is possible across all dairy systems and regions. Although there is a wide variety of production systems globally, there are opportunities for all to reduce greenhouse gas emission (GHG) intensity.1
- Collaboration is needed to reduce dairy’s emissions. Many climate, poverty, and malnutrition challenges can be addressed through adoption of best practices in similar dairy systems.2
- Reducing methane may be key to fast results. Methane, a primary GHG produced by ruminant livestock, is short-lived. As a result, more reductions in methane would have a more immediate effect on warming.3
- Dairy already has the means to reduce a significant proportion of emissions. 4 Initial evidence suggests emissions can be reduced up to 40 percent in some systems by improving productivity and resource use efficiency.
- Defining terminologies and targets will focus efforts to achieve the best results. As indicated in the Intergovernmental Panel on Climate Change (IPCC) Special Report: Global Warming of 1.5°C, dairy’s carbon dioxide emissions need to strive to Net Zero, but its methane reduction can range from 24-47 percent, and its nitrous oxide reduction can be 26 percent.5
“Our initial analysis suggests that wider use of existing GHG mitigation technologies will make an important impact in reducing dairy’s emissions in the short term, while the development of new innovations takes place,” said Hayden Montgomery, Special Representative of GRA. “This initiative may ultimately act as a blueprint for other livestock sectors,” he added.
For more information about Pathways to Dairy Net Zero , visit: www.GlobalDairyPlatform.com/PathwaysToDairyNetZero .
You can register here for the UN Food Systems Pre-Summit affiliated session “Raising the climate ambition for the agriculture sector: An approach from dairy” on Monday, July 26, at 19:30 CEST.
References:
- Food and Agriculture Organization of the United Nations (FAO). 2010. Greenhouse Gas Emissions from the Dairy Sector: A Life Cycle Assessment. Available at: http://www.fao.org/3/k7930e/k7930e00.pdf [Accessed July 2021].
- Food and Agriculture Organization of the United Nations (FAO). 2019. Climate change and the global dairy cattle sector: The role of the dairy sector in a low‐carbon future. Available at: http://www.fao.org/3/CA2929EN/ca2929en.pdf [Accessed July 2021].
- UN Environment Programme. 2021. Global Methane Assessment: Benefits and Costs of Mitigating Methane Emissions. Available at: https://www.unep.org/resources/report/global-methane-assessment-benefits-and-costs-mitigating-methane-emissions [Accessed July 2021].
- Gerber PJ, Steinfeld H, Henderson B, et al. 2013. Tackling climate change through livestock – A global assessment of emissions and mitigation opportunities. Food and Agriculture Organization of the United Nations (FAO), Rome. Available at: http://www.fao.org/3/i3437e/i3437e.pdf [Accessed July 2021].
- The Intergovernmental Panel on Climate Change (IPCC). 2018. Global warming of 1.5°C. An IPCC Special Report on the impacts of global warming of 1.5°C above pre-industrial levels and related global greenhouse gas emission pathways, in the context of strengthening the global response to the threat of climate change, sustainable development, and efforts to eradicate poverty. Available at: https://www.ipcc.ch/site/assets/uploads/sites/2/2019/06/SR15_Full_Report_Low_Res.pdf [Accessed July 2021].
About Pathways to Dairy Net Zero
This is a vibrant, growing movement, the first of its kind in the world. It brings together dairy production systems of every size and type, as well as organizations throughout the dairy supply chain. Collaborators include Global Dairy Platform, International Dairy Federation, Sustainable Agriculture Initiative Platform, International Livestock Research Institute, Dairy Sustainability Framework and IFCN Dairy Research Network. The Global Research Alliance on Agricultural Greenhouse Gases is a knowledge partner.
www.GlobalDairyPlatform.com/PathwaysToDairyNetZero
View source version on businesswire.com: https://www.businesswire.com/news/home/20210726005299/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
